Free
All Subscriber Access
BiQ: Happy Last Day of 2025!
BiQ: Quick Comparison of Leading Clinical-Stage Regimens for 1L mPDAC
BiQ: Happy Holidays from BiQ!
BiQ: My View on Near-Term Market Volatility 12/15/25
BiQ: FDA Approves CARDAMYST for the Treatment of PSVT (MIST)
BiQ: New Live BiQ Active Portfolio, BiQ Cheat Sheets, and Membership Plans for 2026
BiQ: A few final thoughts about Medicenna--for now. 12/10/25 (MDNAF)
BiQ: The Ziftomenib-Revumenib Debate 12/10/25 (KURA, SNDX)
BiQ: BiQ Annual Subscription Pricing
BiQ: Discontinuing Support for the BiQ Public Chat Server